Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Journal of Virology|June 19, 2009
Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavirKlára Grantz Sasková, Milan Kozísek, Pavlína Rezácová, et al.Journal of Viral Hepatitis|April 29, 2025
Epidemiological Burden of Hepatitis Delta Virus in the United StatesElizabeth M Marlowe, Brooke E Swanson, Susan E Realegeno, et al.Antimicrobial Agents and Chemotherapy|February 19, 2009
Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibilityVici Varghese, Yumi Mitsuya, Rajin Shahriar, et al.The Journal of Infectious Diseases|April 3, 2007
The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patientGary Blick, Ron M Kagan, Eoin Coakley, et al.Protein Science : a Publication of the Protein Society|June 19, 2008
Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavirKlára Grantz Sasková, Milan Kozísek, Martin Lepsík, et al.Retrovirology|February 15, 2008
Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptaseMarleen C D G Huigen, Petronella M van Ham, Loek de Graaf, et al.Journal of Clinical Microbiology|April 29, 2020
Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 by Use of Real-Time Reverse Transcription-PCRAmy A Rogers, Russell E Baumann, Gwynngelle A Borillo, et al.Plos One|October 3, 2012
A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patientsRon M Kagan, Erik P Johnson, Martin Siaw, et al.AIDS Research and Human Retroviruses|July 24, 2013
Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjectsRon M Kagan, Erik P Johnson, Martin F Siaw, et al.Antiviral Research|September 30, 2010
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discoverySoo-Yon Rhee, Severine Margeridon-Thermet, Mindie H Nguyen, et al.Pageof 3